GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guard Therapeutics International AB (OSTO:GUARD) » Definitions » Deferred Policy Acquisition Costs

Guard Therapeutics International AB (OSTO:GUARD) Deferred Policy Acquisition Costs


View and export this data going back to 2013. Start your Free Trial

What is Guard Therapeutics International AB Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Guard Therapeutics International AB (OSTO:GUARD) Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 22, Lund, SWE, 223 63
Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful treatment of acute kidney injuries.